Targeting RNA-splicing for SMA Treatment

Overview

Journal Mol Cells

Publisher Elsevier

Specialties Cell Biology
Molecular Biology

Date 2012 Mar 3

PMID 22382684

Citations 15

Authors

Jianhua Zhou

Xuexiu Zheng

Haihong Shen

Affiliations

Soon will be listed here.

Abstract

The central dogma of DNA-RNA-protein was established more than 40 years ago. However, important biological processes have been identified since the central dogma was developed. For example, methylation is important in the regulation of transcription. In contrast, proteins, are more complex due to modifications such as phosphorylation, glycosylation, ubiquitination, or cleavage. RNA is the mediator between DNA and protein, but it can also be modulated at several levels. Among the most profound discoveries of RNA regulation is RNA splicing. It has been estimated that 80% of pre-mRNA undergo alternative splicing, which exponentially increases biological information flow in cellular processes. However, an increased number of regulated steps inevitably accompanies an increased number of errors. Abnormal splicing is often found in cells, resulting in protein dysfunction that causes disease. Splicing of the survival motor neuron (SMN) gene has been extensively studied during the last two decades. Accumulating knowledge on SMN splicing has led to speculation and search for spinal muscular atrophy (SMA) treatment by stimulating the inclusion of exon 7 into SMN mRNA. This mini-review summaries the latest progress on SMN splicing research as a potential treatment for SMA disease.

Citing Articles

Switching of RNA splicing regulators in immature neuroblasts during adult neurogenesis.

Bernou C, Mouthon M, Daynac M, Kortulewski T, Demaille B, Barroca V Elife. 2024; 12.

PMID: 39576691 PMC: 11584179. DOI: 10.7554/eLife.87083.

Molecular Mechanism of Resistance to Apple Pathotype in Apple by Alternative Splicing of Transcription Factor .

Zeng X, Wu C, Zhang L, Lan L, Fu W, Wang S Int J Mol Sci. 2024; 25(8).

PMID: 38673937 PMC: 11050356. DOI: 10.3390/ijms25084353.

PacBio Iso-Seq Improves the Rainbow Trout Genome Annotation and Identifies Alternative Splicing Associated With Economically Important Phenotypes.

Ali A, Thorgaard G, Salem M Front Genet. 2021; 12:683408.

PMID: 34335690 PMC: 8321248. DOI: 10.3389/fgene.2021.683408.

Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis.

Chikhale R, Sinha S, Wanjari M, Gurav N, Ayyanar M, Prasad S Mol Divers. 2021; 25(3):1889-1904.

PMID: 33492566 PMC: 7829483. DOI: 10.1007/s11030-021-10183-w.

Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology.

Wang Y, Xu C, Ma L, Mou Y, Zhang B, Zhou S Life Sci Alliance. 2019; 2(2).

PMID: 30910806 PMC: 6435041. DOI: 10.26508/lsa.201800268.

References

Porensky P, Mitrpant C, McGovern V, Bevan A, Foust K, Kaspar B . A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet. 2011; 21(7):1625-38. PMC: 3298284. DOI: 10.1093/hmg/ddr600. View

Wickens M, Goldstrohm A . Molecular biology. A place to die, a place to sleep. Science. 2003; 300(5620):753-5. DOI: 10.1126/science.1084512. View

Villemaire J, Dion I, Elela S, Chabot B . Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides. J Biol Chem. 2003; 278(50):50031-9. DOI: 10.1074/jbc.M308897200. View

Hua Y, Zhou J . Rpp20 interacts with SMN and is re-distributed into SMN granules in response to stress. Biochem Biophys Res Commun. 2004; 314(1):268-76. DOI: 10.1016/j.bbrc.2003.12.084. View

Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, Ravassard P . Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet. 2010; 20(4):681-93. DOI: 10.1093/hmg/ddq514. View

Forch P, Valcarcel J . Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1. Apoptosis. 2001; 6(6):463-8. DOI: 10.1023/a:1012441824719. View

Young P, DiDonato C, Hu D, Kothary R, Androphy E, Lorson C . SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1. Hum Mol Genet. 2002; 11(5):577-87. DOI: 10.1093/hmg/11.5.577. View

Lunn M, Root D, Martino A, Flaherty S, Kelley B, Coovert D . Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem Biol. 2004; 11(11):1489-93. PMC: 3160629. DOI: 10.1016/j.chembiol.2004.08.024. View

Schrank B, Gotz R, Gunnersen J, Ure J, Toyka K, Smith A . Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A. 1997; 94(18):9920-5. PMC: 23295. DOI: 10.1073/pnas.94.18.9920. View

10.

Singh N, Shishimorova M, Cao L, Gangwani L, Singh R . A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. RNA Biol. 2009; 6(3):341-50. PMC: 2734876. DOI: 10.4161/rna.6.3.8723. View

11.

Pagliardini S, Giavazzi A, Setola V, Lizier C, Di Luca M, Debiasi S . Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum Mol Genet. 1999; 9(1):47-56. DOI: 10.1093/hmg/9.1.47. View

12.

Andreassi C, Jarecki J, Zhou J, Coovert D, Monani U, Chen X . Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet. 2001; 10(24):2841-9. DOI: 10.1093/hmg/10.24.2841. View

13.

Zhang H, Pan F, Hong D, Shenoy S, Singer R, Bassell G . Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci. 2003; 23(16):6627-37. PMC: 6740639. View

14.

Massenet S, Pellizzoni L, Paushkin S, Mattaj I, Dreyfuss G . The SMN complex is associated with snRNPs throughout their cytoplasmic assembly pathway. Mol Cell Biol. 2002; 22(18):6533-41. PMC: 135628. DOI: 10.1128/MCB.22.18.6533-6541.2002. View

15.

Hua Y, Vickers T, Baker B, Bennett C, Krainer A . Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol. 2007; 5(4):e73. PMC: 1820610. DOI: 10.1371/journal.pbio.0050073. View

16.

Rodriguez-Martin T, Garcia-Blanco M, Mansfield S, Grover A, Hutton M, Yu Q . Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies. Proc Natl Acad Sci U S A. 2005; 102(43):15659-64. PMC: 1266082. DOI: 10.1073/pnas.0503150102. View

17.

Meister G, Buhler D, Pillai R, Lottspeich F, Fischer U . A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs. Nat Cell Biol. 2001; 3(11):945-9. DOI: 10.1038/ncb1101-945. View

18.

Voigt T, Meyer K, Baum O, Schumperli D . Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing. Neuromuscul Disord. 2010; 20(11):744-52. DOI: 10.1016/j.nmd.2010.06.010. View

19.

Dickson A, Osman E, Lorson C . A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo. Hum Gene Ther. 2009; 19(11):1307-15. PMC: 2940461. DOI: 10.1089/hum.2008.067. View

20.

Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L . Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995; 80(1):155-65. DOI: 10.1016/0092-8674(95)90460-3. View